MAPT and Alzheimer disease: Lower CSF total tau (t-tau) and phosphorylated tau (p-tau) levels have been observed in individuals with subjective cognitive impairment and cognitively normal (CN) status compared to those with mild cognitive impairment (MCI), mild AD, and moderate to severe AD.